###begin article-title 0
###xml 114 133 110 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 114 133 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Association of the Gene Polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with Patterns of Reinfection with Schistosoma mansoni
###end article-title 0
###begin p 1
Conceived and designed the experiments: MRG WES DMK DGC. Performed the experiments: MRG. Analyzed the data: MRG CLB DGC. Contributed reagents/materials/analysis tools: PNM WES DMK DGC. Wrote the paper: MRG. Oraganized and implemented longitudinal field work: PNM DMK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 299 318 299 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 269 272 <span type="species:ncbi:9606">men</span>
###xml 299 318 <span type="species:ncbi:6183">Schistosoma mansoni</span>
The immunologic findings that most consistently correlate with resistance in human schistosomiasis are high levels of IgE and low levels of IgG4. We have genotyped gene and promoter polymorphisms of cytokines associated with regulation of these isotypes in a cohort of men occupationally exposed to Schistosoma mansoni in western Kenya and evaluated their patterns with respect to resistance and susceptibility to reinfection after treatment and cure with praziquantel (PZQ).
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 335 338 <span type="species:ncbi:9606">men</span>
###xml 557 560 <span type="species:ncbi:9606">men</span>
In this cohort, polymorphisms in IL-4 (-590T high IgE), IL-13 (-1055T high producer) and IFN-gamma (+874A high producer) demonstrated several correlations with resistance to reinfection. Resistance to reinfection was significantly correlated with the heterozygous IL-4 -590 genotype C/T (OR 3.5, [CI 1.2, 10.2]) compared to T/T. Among men with a homozygous IL-13 genotype CC/TT, having a T allele at the IFN-gamma +874 position increased the odds of resistance relative to individuals with the IFN-gamma +874 A/A genotype (OR = 17.5 [CI 3.0, 101.5]). Among men with homozygous A/A IFN-gamma genotype, the heterozygous IL-13 genotype C/T was associated with resistance relative to the homozygous C/C or T/T genotypes (OR = 22.5 [CI 3.5, 144.4]). No increases in odds of resistance were found in relation to the IL-13 genotype among those with a T allele in the IFN-gamma gene or in relation to the IFN-gamma genotype among those with a heterozygous IL-13 genotype. Calculation of the attributable proportion of resistance showed a significant synergistic interaction between IL-13 -1055 C/T and IL-4 -590 C/T.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
The identified polymorphisms do not by themselves confer resistance or susceptibility, but we propose that these genotypes allow the resistant phenotype to be developed and expressed upon suitable immune exposure. Based on the literature, these polymorphisms contribute to the regulation of their respective cytokines, likely leading to downstream differences in the production and interrelationships of critical defense mechanisms.
###end p 7
###begin title 8
Author Summary
###end title 8
###begin p 9
###xml 26 32 <span type="species:ncbi:9606">people</span>
###xml 205 211 <span type="species:ncbi:9606">people</span>
###xml 882 885 <span type="species:ncbi:9606">men</span>
###xml 1156 1162 <span type="species:ncbi:9606">people</span>
Approximately 200 million people have schistosomiasis in parts of Africa, South America, the Middle East, the Caribbean and Asia. Several studies of multiple treatments and reinfections indicate that some people develop resistance to reinfection. Of all the immunologic findings associated with such studies, the most consistent observation is that resistance (usually defined as lower levels of infection upon reinfection) correlates with high IgE and low IgG4 antibodies against schistosome antigens. Our studies test whether single nucleotide polymorphisms residing in the gene or promoter regions of cytokines pivotal in controlling production of these antibody isotypes are different amongst those that develop resistance to reinfection as opposed to those that do not. Through genotyping of these polymorphisms in a cohort of occupationally exposed car washers, we found that men with certain genotypic patterns of polymorphisms in IL-4, IFN-gamma, and IL-13 were significantly more likely to be resistant to reinfection than those with different patterns. These data provide initial insights into the potential genetic foundation of propensities of people to develop resistance to reinfection by schistosomes, and offer a basis for further molecular studies of how these polymorphisms might work at the transcriptional and gene product level in cells stimulated by schistosome antigens.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 271 274 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Butterworth1">[1]</xref>
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Dunne1">[2]</xref>
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Li1">[3]</xref>
###xml 283 286 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Wilkins1">[4]</xref>
###xml 534 537 534 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Caldas1">[5]</xref>
###xml 538 541 538 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Demeure1">[6]</xref>
###xml 542 545 542 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Gomes1">[7]</xref>
###xml 546 549 546 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Gounni1">[8]</xref>
###xml 550 553 550 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Grogan1">[9]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Grogan2">[10]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Hagan1">[11]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Li2">[12]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Rihet1">[13]</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Satti1">[14]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-vanDerKleij1">[15]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Webster1">[16]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Webster2">[17]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Zhang1">[18]</xref>
###xml 726 730 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Brito1">[19]</xref>
###xml 731 735 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-ElRidi1">[20]</xref>
###xml 736 740 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-RibeirodeJesus1">[21]</xref>
###xml 741 745 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Viana1">[22]</xref>
###xml 72 78 <span type="species:ncbi:9606">humans</span>
There have been many studies of resistance to schistosome infections in humans following treatment and reinfection. Such studies involve documentation of cases of schistosomiasis, their treatment and cure, and examinations at a later date to see if reinfections occurred [1],[2],[3],[4]. Of all the immunologic findings associated with these investigations, the most consistent observation is that resistance (usually defined as lower levels of infection) correlates with high IgE and low IgG4 antibodies against schistosome antigens [5],[6],[7],[8],[9],[10],[11],[12],[13],[14],[15],[16],[17],[18]. Other studies have reported that production of IFN-gamma and IL-5 to schistosome antigens are also correlated with resistance [19],[20],[21],[22].
###end p 11
###begin p 12
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Dessein1">[23]</xref>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Marquet1">[24]</xref>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Marquet2">[25]</xref>
###xml 113 119 <span type="species:ncbi:9606">humans</span>
A genetic region (SM1) has been identified that shows a strong positive correlation to the level of infection in humans [23]. SM1 maps to chromosome 5 in the 5q31-q33 region that contains several genes associated with immune responses [24],[25]. These genes code for proteins that are associated with the regulation of Th2-type responses such as IL-3, IL-4, IL-5, IL-9, and IL-13 and IgE. Polymorphisms in these cytokines that lead to an increase or decrease in cytokine levels could influence the antibody isotypes and cellular interactions that in turn may contribute to resistance or susceptibility of individuals to reinfection with schistosomiasis.
###end p 12
###begin p 13
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Wen1">[26]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Verra1">[27]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Bacharier1">[28]</xref>
###xml 158 165 <span type="species:ncbi:9606">infants</span>
###xml 335 343 <span type="species:ncbi:9606">children</span>
There have been contradictory reports on the effect the IL-4 -590 C/T (rs 2243250) polymorphism has on IgE levels in different settings. One group found that infants with a IL-4 -590 C allele had a higher risk of elevated IgE in their cord blood [26]. However, it was also reported that total IgE levels were significantly elevated in children with severe malaria carrying the -590T allele [27]. It is well known that IL-4 plays an important role in IgE class switching [28] and reports that the -590 C/T polymorphism are associated with differing amounts of IgE made it a candidate for this study.
###end p 13
###begin p 14
###xml 160 174 160 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. haematobium</italic>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Kouriba1">[29]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-vanderPouwKraan1">[30]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Cameron1">[31]</xref>
###xml 607 617 607 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 786 790 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Vladich1">[32]</xref>
###xml 875 879 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Graves1">[33]</xref>
###xml 890 894 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-He1">[34]</xref>
###xml 1048 1052 1040 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Vladich1">[32]</xref>
###xml 160 174 <span type="species:ncbi:6185">S. haematobium</span>
###xml 607 617 <span type="species:ncbi:6183">S. mansoni</span>
Kouriba, et al. reported that IL-13 -1055C (rs 1800925) and -591A (rs 2069743) were associated with the upper 10% infection levels in individuals infected with S. haematobium (susceptibility) [29]. Van der Pouw Kraan et al. described an NF-AT binding site at IL-13 -1055 that showed increased binding of nuclear proteins with the T allele [30]. Furthermore, it was reported that transcription of the IL-13 -1055T allele was enhanced in Th2 polarized CD4+ cells, but not in nonpolarized (i.e., Th0) CD4+ T cells [31]. Thus, the IL-13-1055 polymorphism, and possibly -591, could be important in resistance to S. mansoni. The R130Q SNP (G/A) (rs 20541) in IL-13 causes a replacement of arginine with glutamine in alpha helix D, a region involved in IL-13 interactions with IL-13 receptors [32]. The glutamine variant has been associated with increased levels of total serum IgE [33] and atopy [34]. It has also been shown that soluble IL-13Ralpha2 (an IL-13 decoy receptor) neutralizes the arginine variant more effectively than the glutamine variant [32]. This may suggest a possible feedback mechanism that could account for increased total serum IgE in the glutamine variant.
###end p 14
###begin p 15
###xml 188 192 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Brito1">[19]</xref>
###xml 193 197 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-ElRidi1">[20]</xref>
###xml 198 202 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-RibeirodeJesus1">[21]</xref>
###xml 379 383 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Pravica1">[35]</xref>
While most studies have found that Th2 responses are associated with resistance to reinfection with schistosomiasis, other studies found that IFN-gamma production correlates to resistance [19],[20],[21]. Pravica et al. showed that the +874T (rs 2430561) allele corresponds with high production of IFN-gamma and that the A/T site coincides with a putative NF-kappa B binding site [35]. These studies prompted us to include the IFN-gamma +874 polymorphism in our study.
###end p 15
###begin p 16
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Akdis1">[36]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-EdwardsSmith1">[37]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Karjalainen1">[38]</xref>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Turner1">[39]</xref>
IL-10 has been shown to influence IgE and IgG4 production [36]. Differential production of IL-10 has been shown to be associated with different allelic variants of the IL-10 promoter (-1082 A/G [rs 1800896], -819 T/C [rs 1800871], and -592 A/C [rs 1800872]). The different haplotypes that have been associated with production of IL-10 are as follows: "high" IL-10 producer haplotype (GCC/GCC), "intermediate" producer haplotypes (GCC/ACC, GCC/ATA), and "low" producer haplotypes (ATA/ATA, ACC/ATA, ACC/ACC) [37]. Indeed, the ATA/ATA haplotype has been associated with increased eosinophil counts and circulating IgE in adult asthma when compared to the other possible haplotypes [38]. However, the group that first described these polymorphisms conclude that high IL-10 production was dependant on having a G in the -1082 position independent of the -819 and -592 polymorphisms [39]. Furthermore, Ruess et al. has shown that -1082A binds PU.1, which can inhibit gene transcription.
###end p 16
###begin p 17
###xml 439 443 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Karanja1">[40]</xref>
###xml 444 448 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Mwinzi1">[41]</xref>
###xml 367 370 <span type="species:ncbi:9606">men</span>
Based on these and other studies, we examined possible relationships between single nucleotide polymorphisms in the IL-4 (-590 C/T), IL-13[(-1055 C/T), (-591A/G), (R130Q G/A)], IL-10 (-1082 A/G; -819 C/T; -592 C/A), and IFN-gamma (+874A/T) genes or promoters in relation to resistance and susceptibility to schistosomiasis of a cohort of occupationally exposed adult men many of whom we have studied longitudinally for as long as 12 years [40],[41].
###end p 17
###begin title 18
Materials and Methods
###end title 18
###begin title 19
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants
###end title 19
###begin p 20
###xml 100 110 100 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 120 141 120 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Biomphalaria sudanica</italic>
###xml 297 307 297 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 100 110 <span type="species:ncbi:6183">S. mansoni</span>
###xml 120 141 <span type="species:ncbi:112527">Biomphalaria sudanica</span>
###xml 237 249 <span type="species:ncbi:9606">participants</span>
###xml 297 307 <span type="species:ncbi:6183">S. mansoni</span>
###xml 478 481 <span type="species:ncbi:9606">men</span>
The field site for this study was the western Kenyan city of Kisumu on the shores of Lake Victoria. S. mansoni-infected Biomphalaria sudanica snails have been identified (data unpublished) in the area around the exposure site. The study participants were all car washers occupationally exposed to S. mansoni as they stood in Lake Victoria, using its waters to wash cars driven into the shallow areas of the lake. This study was performed on a total of 87 car washers (all adult men). However, it was not possible to use all data from every individual in every analysis; some epidemiologic data regarding infections, cures or reinfections were insufficient or incomplete.
###end p 20
###begin p 21
###xml 385 395 385 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 641 651 641 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 342 354 <span type="species:ncbi:9606">participants</span>
###xml 385 395 <span type="species:ncbi:6183">S. mansoni</span>
###xml 606 618 <span type="species:ncbi:9606">participants</span>
###xml 641 651 <span type="species:ncbi:6183">S. mansoni</span>
###xml 699 702 <span type="species:ncbi:9606">men</span>
###xml 856 859 <span type="species:ncbi:9606">men</span>
This investigation was approved by the Institutional Review Boards of the University of Georgia and the Centers for Diseases Control and Prevention, the Scientific Steering Committee of the Kenya Medical Research Institute (KEMRI), and the National Ethics Review Committee of Kenya. After obtaining written informed consent and enrolling the participants, we examined their stools for S. mansoni eggs and for other helminth ova by the modified Kato-Katz method (Vestergaard-Frandsen, Denmark). In most instances, this involved 2 slides per stool specimen from 3 stool specimens over a one week period. The participants who were positive for S. mansoni were treated with 40 mg/kg praziquantel (PZQ); men positive for other soil-transmitted helminth eggs were treated with 400 mg albendazole. Individuals' stools were checked 6 weeks after treatment and the men were retreated if still egg positive. Upon becoming egg negative, they were then followed by stool examination every 4 weeks to determine their time to reinfection as a means of determining their relative resistance to reinfection (see below).
###end p 21
###begin title 22
DNA preparation
###end title 22
###begin p 23
White blood cell-containing buffy coats were separated using the Ficoll-hypaque technique from blood obtained for immunological assays. The buffy coats were stored at -20degreesC and DNA was isolated at KEMRI/CGHR laboratories using the Wizard(R) Genomic DNA Purification Kit from Promega. DNA from 300 microl of buffy coat for each car washer was isolated per the manufacturer's instructions. Dried DNA pellets were then transported to Athens, Georgia, USA for genotyping.
###end p 23
###begin title 24
PCR reactions
###end title 24
###begin p 25
###xml 277 278 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 293 296 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 369 393 353 377 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGCCTTGTGAGGAGGGTCAC</named-content>
###xml 411 435 395 419 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAGTCTCTGCAGGATCAACC</named-content>
###xml 435 439 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Howard1">[42]</xref>
###xml 858 859 796 797 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 874 877 812 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1185 1212 1093 1120 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAGCCTGGCCCAGTTAAGAGTTT</named-content>
###xml 1230 1255 1138 1163 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTAATTCCTCCTTGGCCCCACT</named-content>
###xml 1255 1259 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Kouriba1">[29]</xref>
###xml 1443 1444 1335 1336 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1459 1462 1351 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1770 1793 1632 1655 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGCGTTCTACTCACGTGCT</named-content>
###xml 1811 1834 1673 1696 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGCACAGGCTGAGGTCTAA</named-content>
###xml 1834 1838 1696 1700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Heinzmann1">[43]</xref>
###xml 2021 2022 1867 1868 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2037 2040 1883 1886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 2349 2372 2165 2188 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACTAGGCCTCACCTGATACG</named-content>
###xml 2390 2413 2206 2229 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTTGTAATGCAGTCCTCCTG</named-content>
###xml 2413 2417 2229 2233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Gyan1">[44]</xref>
PCR reactions of IL-13 and IL-4 SNPs were performed on a PTC-200 DNA Engine from MJ Research. PCR of the IL-13 -1055 C/T was conducted in a 50 microl reaction containing 100 ng DNA, 5 microl of 1x Qiagen PCR buffer, 0.5 microM of each dNTP, 0.4 microM of each primer, 1 mM MgCl2, and 2.5 U of Taq polymerase (Qiagen). The following sequences were used: forward primer, 5'-ATGCCTTGTGAGGAGGGTCAC; reverse primer, 5'-CCAGTCTCTGCAGGATCAACC[42]. Initial denaturation was performed at 95degreesC for 3 min followed by 30 cycles of PCR with the following conditions: 95degreesC for 30 sec, 62degreesC for 30 sec for annealing, 72degreesC for 1 min, and a final 72degreesC for 3 min. PCR of the IL-13 -591 A/G was conducted in a 50 microl reaction containing 100 ng DNA, 5 microl of 1x Qiagen PCR buffer, 0.5 microM of each dNTP, 0.4 microM of each primer, 3 mM MgCl2, and 2.5 U of Taq polymerase (Qiagen). Initial denaturation was performed at 94degreesC for 5 min followed by 34 cycles of PCR with the following conditions: 94degreesC for 1 min, 61degreesC for 45 sec for annealing, 72degreesC for 45 sec, and a final 72degreesC for 3 min. The following sequences were used: forward primer, 5'-CCAGCCTGGCCCAGTTAAGAGTTT; reverse primer, 5'-CTAATTCCTCCTTGGCCCCACT[29]. PCR of the IL-13 +130 G/A was conducted in a 50 microl reaction containing 100 ng DNA, 5 microl of 1x Qiagen PCR buffer, 0.5 microM of each dNTP, 0.4 microM of each primer, 1 mM MgCl2, and 2.5 U of Taq polymerase (Qiagen). Initial denaturation was performed at 94degreesC for 5 min followed by 34 cycles of PCR with the following conditions: 94degreesC for 1 min, 60degreesC for 45 sec for annealing, 72degreesC for 45 sec, and a final 72degreesC for 3 min. The following sequences were used: forward primer, 5'-TGGCGTTCTACTCACGTGCT; reverse primer, 5'-CAGCACAGGCTGAGGTCTAA[43]. PCR of the IL-4 -590 C/T was conducted in a 50 microl reaction containing 100 ng DNA, 5 microl of 1x Qiagen PCR buffer, 0.5 microM of each dNTP, 0.4 microM of each primer, 1 mM MgCl2, and 2.5 U of Taq polymerase (Qiagen). Initial denaturation was performed at 95degreesC for 5 min followed by 31 cycles of PCR with the following conditions: 94degreesC for 30 sec, 59degreesC for 30 sec for annealing, 72degreesC for 30 sec, and a final 72degreesC for 3 min. The following sequences were used: forward primer, 5'-ACTAGGCCTCACCTGATACG; reverse primer, 5'-GTTGTAATGCAGTCCTCCTG[44].
###end p 25
###begin title 26
Genotyping
###end title 26
###begin p 27
Purified PCR products of the IL-13 -1055 C/T and IL-4 -590 C/T PCR reactions were sequenced using the reverse primers for each and the forward primers for IL-13 +130 G/A and IL-13 -591 A/G on an ABI 3100 by the Office of Research Services at The University of Georgia. The polymorphisms IL-10 -1082, IL-10 -819, IL-10 -592, and IFN-gamma +874A/T were genotyped using sequence-specific primers (SSP) in The Cytokine Genotyping Tray (One Lambda; Canoga Park, CA) as per the manufacturer's instructions.
###end p 27
###begin title 28
Resistance
###end title 28
###begin p 29
###xml 120 132 <span type="species:ncbi:9606">participants</span>
###xml 307 319 <span type="species:ncbi:9606">participants</span>
###xml 436 448 <span type="species:ncbi:9606">participants</span>
###xml 726 729 <span type="species:ncbi:9606">men</span>
###xml 891 894 <span type="species:ncbi:9606">men</span>
###xml 1060 1063 <span type="species:ncbi:9606">men</span>
###xml 1242 1245 <span type="species:ncbi:9606">men</span>
###xml 1709 1712 <span type="species:ncbi:9606">Men</span>
###xml 1863 1866 <span type="species:ncbi:9606">men</span>
###xml 1912 1915 <span type="species:ncbi:9606">men</span>
Resistance is based on the number of cars washed from the time of a successful cure until the next reinfection. For all participants, the number of cars washed between each cure and reinfection over the entire duration of the study was plotted and the patterns examined. Two dominant patterns emerged, with participants either becoming reinfected after washing approximately the same number of cars between each cure and reinfection or participants washing progressively more cars between successive cure-reinfection intervals. The majority of those in the former group (classified as "susceptible") became reinfected after washing approximately 250-300 cars regardless of how many times they were cured and reinfected. Those men who demonstrated a pattern of increasing numbers of cars washed before subsequent reinfections were classified as "developing resistance" during this study. All men classified as "developing resistance" eventually washed at least 450 cars before reinfection after being followed for at least 3 cure-to-reinfection intervals. Some men (classified as "initially resistant") washed at least 450 cars after the initial cure and continued to wash a high number of cars before each reinfection. For analysis purposes, men classified as "developing resistance" and "initially resistant" were grouped into a single "resistant" category because frequencies of genotypes did not differ significantly between these two groups, and conceptually these groups indicate either the existence of established resistance or the ability to develop resistance. Resistance data are based on a mean follow-up time of 7.5 years (range 0.9-12.2 yrs) months and a mean of 7 cure-to-reinfection intervals. Men were excluded from the analysis when the number of cars washed between each cure and reinfection could not be classified into a particular pattern (3 men) or they had insufficient follow up data (16 men) for accurate classification.
###end p 29
###begin title 30
Statistical methods
###end title 30
###begin p 31
Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) for the association between resistance and each genotype were calculated using univariate analyses and in a multivariate logistic regression model containing variables for all three genotypes. To test for interactions between genotypes, categorical interaction terms with 4 levels were created for each possible two-way interaction between the 3 dichotomized genotypes. The combination of alleles with the lowest frequency of resistant subjects was considered the referent category in each set of terms. Separate logistic regression models were run for each series of two-way interaction terms. Inclusion of a term for the third genotype did not appreciably change the results of any of the interaction models and was thus ultimately not included in any of the reported analyses of interactions.
###end p 31
###begin p 32
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Ahlbom1">[45]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Ahlbom1">[45]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Kalilani1">[46]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Rothman1">[47]</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Andersson1">[48]</xref>
###xml 1115 1119 1115 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Hosmer1">[49]</xref>
Interactions were assessed on both a multiplicative and additive scale. Multiplicative interactions are indicative of the need to estimate stratum-specific effects for the combination of two genotypes, rather than a single estimate for each genotype, in order to improve the fit of the model to the data [45]. Multiplicative interactions were assessed by testing the significance of an interaction term between two genotypes in the logistic regression models by the Wald test. As many researchers believe that departure from additivity is a better indicator of biologic interaction than departure from multiplicativity [45],[46], we also calculated the attributable proportion (AP) of resistance due to interactions between two genotypes. A positive AP is indicative of synergy between the two genotypes, while a negative AP indicates antagonism [47]. APs and corresponding 95% CIs for each of the two-way interactions between genotypes were calculated based on the output from the logistic regression models using the code provided by Andersson et al [48] based on the methodology described by Hosmer and Lemeshow [49]. All analyses were performed with SAS version 9.1.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
Distribution of genotypes and resistance
###end title 34
###begin p 35
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t001">Table 1</xref>
###xml 712 719 704 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t001">Table 1</xref>
###xml 246 249 <span type="species:ncbi:9606">men</span>
###xml 308 311 <span type="species:ncbi:9606">men</span>
###xml 532 535 <span type="species:ncbi:9606">men</span>
###xml 1046 1049 <span type="species:ncbi:9606">men</span>
###xml 1078 1081 <span type="species:ncbi:9606">men</span>
###xml 1171 1174 <span type="species:ncbi:9606">men</span>
The distribution of genotypes for each polymorphism and frequency of resistance in each genotype are given in Table 1. A higher percentage of car washers with a T allele (T/T or T/A) at IFN-gamma +874 are resistant (T/A 65.2% and T/T 77.8%) than men that are A/A homozygous (38.9%). For subsequent analyses, men with T/A and T/T at the IFN-gamma +874 position were grouped as the occurrence of resistance for each was significantly higher when compared to homozygous individuals (A/A) and they did not differ from each other. Among men heterozygous (C/T) at the IL-13 -1055 position, 76.0% were resistant to reinfection; whereas only 41.9% of C/C and only 42.9% of T/T individuals were resistant to reinfection (Table 1). Both homozygous genotypes for IL-13 -1055 were grouped for the univariate analysis as the occurrences of resistance in either of those genotypes were substantially lower than in the heterozygous group and they did not differ from each other. The frequency of homozygous C/C at IL-4 -590 was not high enough in our cohort of men to allow analysis. However, men heterozygous (C/T) at IL-4 -590 represent a higher percentage of resistance (70.8%) than men that are T/T homozygous (40.9%). No overt differences are seen in the proportions of the different genotypes of IL-10 (-1082; -819; -592) promoter SNPs in relationship to resistance or susceptibility to reinfection, and as expected due to linkage disequilibrium, SNPs at IL-10 -819 and IL-10 -592 segregate together.
###end p 35
###begin title 36
IFN-gamma +874, IL-13 -1055, IL-13 +130, IL-13 -591, IL-4 -590, IL-10 -1082, IL-10 -819 and IL-10 -592 genotype distributions and percentage of resistance.
###end title 36
###begin title 37
Polymorphisms in IL-13, IFN-gamma, IL-4, and IL-10 and resistance
###end title 37
###begin p 38
###xml 160 167 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t002">Table 2</xref>
###xml 377 384 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t002">Table 2</xref>
###xml 551 558 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t002">Table 2</xref>
###xml 754 761 750 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t002">Table 2</xref>
###xml 865 872 861 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t001">Table 1</xref>
Resistance was significantly associated with the T allele at IFN-gamma +874 (TT and TA) when compared to the homozygous A/A individuals (OR 3.5 [CI 1.3, 9.4]) (Table 2). Car washers heterozygous (C/T) at the IL-13 -1055 position also showed a significant correlation with resistance to reinfection when compared to homozygous (C/C and T/T) car washers (OR 4.4 [CI 1.4, 13.4]) (Table 2), and heterozygousity (C/T) at the IL-4 -590 position correlated significantly with resistance when compared to homozygous (T/T) car washers (OR 3.5 [CI 1.2, 10.2]) (Table 2). These associations remained significant when all three genotypes were included in a multivariate analysis, indicating an independent association between resistance and each of the 3 genotypes (Table 2). For IL-13 -591, there was no significant difference in resistance between the A/A and A/G genotypes (Table 1, p = 0.2399). Having an A allele at the IL-13 +130 position was associated with a modest increase in resistance relative to the homozygous G/G genotype (OR = 2.4 [0.9, 6.7]). However, when IL-13 +130 and IL-13 -1055 were evaluated simultaneously in a logistic regression model, the association between resistance and IL-13 +130 disappeared (OR = 1.4 [0.4, 4.5]), while IL-13 -1055 remained significantly associated with resistance. This suggests that the observed relationship between resistance and IL-13 +130 was spurious and likely due to the close association between IL-13 +130 and IL-13 -1055. Therefore, we only included the IL-13 -1055 polymorphism in further analyses.
###end p 38
###begin title 39
Odds ratios for the associations between individual genotypes and resistance to reinfection by univariate and multivariate analysis.
###end title 39
###begin p 40
adjusted for the other 2 genotypes.
###end p 40
###begin p 41
We found a relationship of borderline significance with IL-10 -819 or -592 (any C versus homozygous G/G or A/A): (OR = 3.1 [0.9, 10.2], p = 0.0577) and resistance to reinfection. These two (-819 and -592) polymorphisms are in tight linkage disequilibrium; hence the results are interchangeable between the two. The OR remained virtually unchanged in a model controlling for the other three significant genotypes, indicating that this possible low-grade association between resistance and the IL-10 polymorphism was not confounded by its association with another genotype. There were no significant additive or multiplicative interactions between IL-10 -819 or -592 and any of the IL-4, IL-13 or IFN-gamma polymorphisms. No significant associations were found with IL-10 -1082 with resistance or susceptibility (data not shown).
###end p 41
###begin title 42
Associations between genotype and resistance within categories of genotype interactions
###end title 42
###begin p 43
###xml 345 352 337 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t003">Table 3</xref>
###xml 622 629 606 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t003">Table 3</xref>
###xml 951 958 927 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t003">Table 3</xref>
###xml 433 436 <span type="species:ncbi:9606">men</span>
###xml 705 708 <span type="species:ncbi:9606">men</span>
###xml 767 770 <span type="species:ncbi:9606">men</span>
###xml 1026 1029 <span type="species:ncbi:9606">men</span>
Combination of the IL-13 -1055 and IFN-gamma +874 genotypes that were independently associated with resistance did not increase the odds of being resistant over having either one of these genotypes alone. However, although all combinations of IL-13 and IFN-gamma genotypes had comparable odds of resistance when compared to the reference group (Table 3), effect modification was seen between the IL-13 and IFN-gamma genotypes. Among men with a homozygous IL-13 genotype, having a T allele at the IFN-gamma +874 position increased the odds of resistance relative to those with the A/A genotype (OR = 17.5 [CI 3.0, 101.5]) (Table 3). There was no association between IFN-gamma genotype and resistance among men with the heterozygous C/T IL-13 genotype. Likewise, among men with homozygous A/A IFN-gamma genotype, the heterozygous IL-13 genotype was associated with resistance relative to the homozygous C/C or T/T genotypes (OR = 22.5 [CI 3.5, 144.4]) (Table 3), while no association between IL-13 and resistance was seen among men with a T allele in the IFN-gamma gene.
###end p 43
###begin title 44
Odds ratios for the associations between genotype and resistance within categories of genotype interaction.
###end title 44
###begin p 45
AP = attributable proportion.
###end p 45
###begin p 46
Wald test for interaction term in logistic regression model.
###end p 46
###begin p 47
###xml 229 236 229 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t003">Table 3</xref>
###xml 388 395 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t003">Table 3</xref>
###xml 759 766 755 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000375-t003">Table 3</xref>
###xml 0 3 <span type="species:ncbi:9606">Men</span>
###xml 239 242 <span type="species:ncbi:9606">Men</span>
###xml 354 357 <span type="species:ncbi:9606">men</span>
Men with a combination of the heterozygous C/T alleles for IL-13 -1055 and IL-4 -590 genes had more than a 20-fold increased odds of resistance relative to those with homozygous alleles at both genes (OR = 20.1 [CI 2.3, 176.0]) (Table 3). Men who were heterozygous for only one of the IL-13 or IL-4 genes were not more likely to be resistant compared to men with both homozygous alleles (Table 3). A significant additive interaction between IL-13 and IL-4 genotypes was detected, with 90% of the resistance among those with heterozygous alleles at both genes attributable to the interaction between the two genes (AP = 0.90 [0.64, 1.15]). In contrast, no significant additive or multiplicative interactions were detected between IL-4 -590 and IFN-gamma +874 (Table 3).
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000375-Karanja1">[40]</xref>
###xml 143 153 143 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 143 153 <span type="species:ncbi:6183">S. mansoni</span>
The car washers in this study are part of a longitudinal study that dates back 12 years [40]. Their exposure (water contact) to infection with S. mansoni is documented by the number of cars washed for payment purposes, providing us with a unique, reliable means to quantify an individual's exposure in an active transmission site over time. This longitudinal field setting allows us to account for water contact as a variable and pose some interesting immunologic and genetic questions with regard to what influences may play a role in determining resistance to reinfection after treatment.
###end p 49
###begin p 50
###xml 71 81 71 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 71 81 <span type="species:ncbi:6183">S. mansoni</span>
###xml 940 943 <span type="species:ncbi:9606">men</span>
We found significant correlates between resistance to reinfection with S. mansoni and the heterozygous (C/T) IL-13 -1055 genotype, any T allele in the IFN-gamma +874 genotype, and the heterozygous (C/T) in the IL-4 -590 genotype by univariate analysis. Furthermore, these associations remained significant when all three genotypes were included in a multivariate analysis, indicating independent associations between resistance and each of the 3 genotypes. However, our data suggest that having a combination of the IL-13 C/T and an IFN-gamma T allele at +874 does not provide increased odds of being resistant over having just one of these genotypes. Instead, both IL-13 C/T and any IFN-gamma T allele demonstrated very high odds of being resistant when compared to the reference group. Our data did, however, show a significant synergistic effect between the IL-13 -1055 C/T and IL-4 -590 C/T genotypes. Thus, the proportion of resistant men seen with a combination of these two cytokine genotypes was much greater than that seen with the sum of the separate effects of IL-13 -1055 C/T and IL-4 -590 C/T on resistance. We interpret these data to indicate that individuals heterozygous at the IL-13 -1055 and IL-4 -590 position are more likely to require fewer reinfections and treatments to become resistant to reinfection than individuals who are homozygous at either position.
###end p 50
###begin p 51
###xml 279 282 <span type="species:ncbi:9606">men</span>
###xml 324 329 <span type="species:ncbi:9606">women</span>
###xml 693 699 <span type="species:ncbi:9606">people</span>
Due to our small sample size, our interaction analysis resulted in wide confidence intervals and we were unable to evaluate 3-way interactions between groups. Also, because car washing is an exclusively male profession at this study site, the associations in this study apply to men and cannot necessarily be generalized to women. However, these analyses provide interesting findings in a situation that provides exceptional exposure data that are not generally available in studies of resistance to reinfection. Clearly our findings need to be investigated further in larger cohorts. However, the current data provide initial insights into the potential genetic foundation of propensities of people to develop resistance to reinfection by schistosomes, and they offer a basis for further molecular studies of how these polymorphisms might work at the transcriptional and gene product level.
###end p 51
###begin title 52
References
###end title 52
###begin article-title 53
###xml 28 33 <span type="species:ncbi:9606">human</span>
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.
###end article-title 53
###begin article-title 54
###xml 27 33 <span type="species:ncbi:9606">humans</span>
Resistance to infection in humans and animal models.
###end article-title 54
###begin article-title 55
###xml 88 94 <span type="species:ncbi:9606">humans</span>
###xml 116 137 <span type="species:ncbi:6182">Schistosoma japonicum</span>
A 2-year prospective study in China provides epidemiological evidence for resistance in humans to re-infection with Schistosoma japonicum.
###end article-title 55
###begin article-title 56
Resistance to reinfection after treatment of urinary schistosomiasis.
###end article-title 56
###begin article-title 57
###xml 33 52 33 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 33 52 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment.
###end article-title 57
###begin article-title 58
###xml 14 33 14 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 14 33 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 37 43 <span type="species:ncbi:9606">humans</span>
Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.
###end article-title 58
###begin article-title 59
###xml 52 71 52 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 52 71 <span type="species:ncbi:6183">Schistosoma mansoni</span>
IgE and IgG4 antibodies in subjects reinfected with Schistosoma mansoni in an endemic area of northeast Brazil.
###end article-title 59
###begin article-title 60
High-affinity IgE receptor on eosinophils is involved in defence against parasites.
###end article-title 60
###begin article-title 61
Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: infected versus uninfected individuals.
###end article-title 61
###begin article-title 62
###xml 86 94 <span type="species:ncbi:9606">children</span>
Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults.
###end article-title 62
###begin article-title 63
###xml 51 74 51 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma haematobium</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 51 74 <span type="species:ncbi:6185">Schistosoma haematobium</span>
Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.
###end article-title 63
###begin article-title 64
###xml 69 92 69 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma haematobium</italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 69 92 <span type="species:ncbi:6185">Schistosoma haematobium</span>
Preferential recognition by human IgE and IgG4 of a species-specific Schistosoma haematobium serine protease inhibitor.
###end article-title 64
###begin article-title 65
###xml 56 75 56 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 56 75 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels.
###end article-title 65
###begin article-title 66
###xml 79 98 79 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 79 98 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Changes in IgE- and Antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.
###end article-title 66
###begin article-title 67
Recognition of schistosome glycolipids by immunoglobulin E: possible role in immunity.
###end article-title 67
###begin article-title 68
###xml 26 45 26 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 26 45 <span type="species:ncbi:6183">Schistosoma mansoni</span>
IgG4 and IgE responses to Schistosoma mansoni adult worms after treatment.
###end article-title 68
###begin article-title 69
###xml 79 98 79 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 79 98 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment.
###end article-title 69
###begin article-title 70
###xml 96 117 96 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma japonicum</italic>
###xml 96 117 <span type="species:ncbi:6182">Schistosoma japonicum</span>
Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum.
###end article-title 70
###begin article-title 71
###xml 185 204 <span type="species:ncbi:6183">Schistosoma mansoni</span>
CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
###end article-title 71
###begin article-title 72
###xml 63 68 <span type="species:ncbi:9606">human</span>
T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium.
###end article-title 72
###begin article-title 73
###xml 26 45 26 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 26 45 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Human immune responses to Schistosoma mansoni vaccine candidate antigens.
###end article-title 73
###begin article-title 74
###xml 104 123 104 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 104 123 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni.
###end article-title 74
###begin article-title 75
Genetics of parasitic infections.
###end article-title 75
###begin article-title 76
###xml 103 122 103 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 103 122 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33.
###end article-title 76
###begin article-title 77
###xml 74 93 74 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 74 93 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33.
###end article-title 77
###begin article-title 78
Association between cord blood IgE and genetic polymorphisms of interleukin-4, the beta-subunit of the high-affinity receptor for IgE, lymphotoxin-alpha, and tumor necrosis factor-alpha.
###end article-title 78
###begin article-title 79
IL4-589 C/T polymorphism and IgE levels in severe malaria.
###end article-title 79
###begin article-title 80
Molecular mechanisms of IgE regulation.
###end article-title 80
###begin article-title 81
###xml 105 128 105 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma haematobium</italic>
###xml 105 128 <span type="species:ncbi:6185">Schistosoma haematobium</span>
Analysis of the 5q31-q33 locus shows an association between IL13-1055 C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections.
###end article-title 81
###begin article-title 82
An IL-13 promoter polymorphism associated with increased risk of allergic asthma.
###end article-title 82
###begin article-title 83
###xml 34 39 <span type="species:ncbi:9606">human</span>
Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation.
###end article-title 83
###begin article-title 84
###xml 109 114 <span type="species:ncbi:9606">human</span>
IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.
###end article-title 84
###begin article-title 85
###xml 138 146 <span type="species:ncbi:9606">children</span>
A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children.
###end article-title 85
###begin article-title 86
###xml 74 82 <span type="species:ncbi:9606">children</span>
Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children.
###end article-title 86
###begin article-title 87
###xml 60 65 <span type="species:ncbi:9606">human</span>
A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production.
###end article-title 87
###begin article-title 88
###xml 41 44 <span type="species:ncbi:7460">bee</span>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells.
###end article-title 88
###begin article-title 89
###xml 74 85 <span type="species:ncbi:11103">hepatitis C</span>
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.
###end article-title 89
###begin article-title 90
Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma.
###end article-title 90
###begin article-title 91
An investigation of polymorphism in the interleukin-10 gene promoter.
###end article-title 91
###begin article-title 92
###xml 31 50 31 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 31 50 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 98 103 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study.
###end article-title 92
###begin article-title 93
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 69 104 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection.
###end article-title 93
###begin article-title 94
Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma.
###end article-title 94
###begin article-title 95
###xml 41 46 <span type="species:ncbi:9606">human</span>
Genetic variants of IL-13 signalling and human asthma and atopy.
###end article-title 95
###begin article-title 96
###xml 116 124 <span type="species:ncbi:9606">children</span>
Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children.
###end article-title 96
###begin article-title 97
Interaction: A word with two meanings creates confusion.
###end article-title 97
###begin article-title 98
Measuring additive interaction using odds ratios.
###end article-title 98
###begin article-title 99
Calculating measures of biological interaction.
###end article-title 99
###begin article-title 100
Confidence interval estimation of interaction.
###end article-title 100
###begin p 101
The authors have declared that no competing interests exist.
###end p 101
###begin p 102
This work was supported by PHS grants AI 053695 and T32 AI060546 from the NIAID, and D43 TW007123 from the FIC, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 102

